Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

Sep 24, 2020
|
staff reporter

NEW YORK – BGI Genomics said on Thursday that it has received CE marking for two multiplexed tests for SARS-CoV-2 and influenza A/B produced by its subsidiary BGI PathoGenesis Pharmaceutical Technology.

Both real-time fluorescent RT-PCR tests are for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B from throat swab samples using a single reaction. One test detects the SARS-CoV-2 ORF1ab gene, while the second test detects the virus's ORF1ab and N genes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Funds Sought for Vaccine Distribution

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

Virus Variant From Spain Now Across UK

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

Unexpected Loss

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

Science Papers on Long Human-Canine Relationship, Population History of Early East Asians, More

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.

Nov
05
Featured Webinar

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

Sponsored by
Roche

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

Nov
11
Featured Webinar

Leveraging Genomics to Accelerate Genetic Improvement in Aquaculture

Sponsored by
Illumina

Selective breeding represents an efficient approach to increase production of aquaculture species by means of improving traits, such as rapid growth, product quality, and disease resistance.

Nov
17
Featured Webinar

Spatial Expression Analyses Elucidates Mechanisms of circRNAs in Cancer

Sponsored by
ACD

Circular RNAs (circRNAs) have recently gained substantial attention in the cancer research field where most, including the putative oncogene ciRS-7 (CDR1as), have been proposed to function as competitive endogenous RNAs (ceRNAs) by “sponging” specific microRNAs.

What's Popular?

In PCR

  1. Bio-Rad Q3 Revenues Jump 15 Percent

  2. Opko Health Q3 Revenues Up 87 Percent

  3. Quidel Q3 Revenues Nearly Triple, Beat Analyst Expectations

  4. Biocartis, Exact Sciences Terminate Oncotype DX Agreement

  5. PerkinElmer SARS-CoV-2 Test Gets Reissued Emergency Use Authorization for Pooled Sampling

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.